-The Times of India MUMBAI: Turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced life-saving drugs for cancer and HIV, is now spilling over to other chronic ailments like diabetes, and threatening to change dynamics of the nearly Rs 70,000 crore Indian pharma market. Triggering a full-blown patent fight with US-based Merck, domestic generic company Glenmark has launched a more affordable version of the multinational's blockbuster...

-The Hindu India may have achieved a success rate of 88 per cent in treatment of tuberculosis - higher than the global treatment success rate of 85 per cent - but HIV-TB co-infection continues to be a cause of major concern, as the percentage of people infected with the twin infection increased substantially between 2010 and 2011. The percentage of TB patients tested for HIV increased nationally from 32 per cent...

-The Times of India The free trade agreement that European Union is pushing India to sign could put an end to India's status as the pharmacy of the developing providing affordable medicines, especially HIV Drugs to countries like Brazil, Thailand, South Africa, Zimbabwe and several others. The negotiations with EU are on at a feverish pace this week in Brussels even before the parliamentary standing committee looking into the free trade...

-The Hindu Doctors must avoid the word even in court depositions The Health Ministry has advised doctors not to use the word ‘rape’ in medical reports on sexual assault victims, and even in court depositions. “Rape is not a medical diagnosis, it is a legal definition, hence the word should not be used while forwarding opinion,” says the latest Instruction Manual for Forensic Medical Examination Report of Sexual Assault (Victim) brought out by...

-The Times of India All antibiotics, TB drugs and other habit-forming medicines may soon come with a label warning users about the dangers of taking them without medical advice. Recommending this to the health ministry as a way to address the problem of drug resistance, a task force has also suggested creating a new category, H1, for these drugs by amending the Drugs and Cosmetics Rules, 1945. Health minister Ghulam Nabi Azad...